India to United States: Levofloxacin Export Trade Route
India has recorded 127 verified shipments of Levofloxacin exported to United States, representing a combined trade value of $3.8M USD. This corridor is served by 16 active Indian exporters, with an average shipment value of $30.3K USD. The leading Indian exporter is ZYDUS LIFESCIENCES LIMITED, which accounts for 46% of total export value with 51 shipments worth $1.8M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $1.8M USD in purchases. The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, DR.REDDY'S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED — together control 79% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Levofloxacin corridor is one of India's established pharmaceutical export routes, with 127 shipments documented worth a combined $3.8M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's levofloxacin manufacturing sector.
Across 16 active suppliers, the average shipment value stands at $30.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with levofloxacin's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 20.1%, placing it at rank #7 among India's top levofloxacin export destinations globally.
On the import side, key buyers of Indian levofloxacin in United States include EVERSANA LIFE SCIENCE SERVICES, DR. REDDYS LABORATORIES, INC, DR. REDDYS LABORATORIES INC and 20 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 55 shipments valued at $1.8M USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ1
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#7
- Annual growth+20.1%
- Demand growth+19.0%
- Regulatory ease85/100
Top 10 Indian Levofloxacin Exporters to United States
Showing top 10 of 16 Indian suppliers exporting Levofloxacin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED Avg $34.4K per shipment | 51 | $1.8M | 45.7% |
| 2 | DR.REDDY'S LABORATORIES LTD Avg $35.2K per shipment | 28 | $985.9K | 25.6% |
| 3 | DR.REDDY'S LABORATORIES LIMITED Avg $27.9K per shipment | 10 | $278.9K | 7.3% |
| 4 | HETERO LABS LIMITED Avg $47.6K per shipment | 5 | $238.0K | 6.2% |
| 5 | MACLEODS PHARMACEUTICALS LTD Avg $18.2K per shipment | 13 | $236.0K | 6.1% |
| 6 | DR REDDYS LABORATORIES LIMITED Avg $29.9K per shipment | 4 | $119.5K | 3.1% |
| 7 | MACLEODS PHARMACEUTICALS LIMITED Avg $39.8K per shipment | 2 | $79.7K | 2.1% |
| 8 | CADILA HEALTHCARE LIMITED Avg $24.7K per shipment | 3 | $74.2K | 1.9% |
| 9 | RUBICON RESEARCH LIMITED Avg $28.0K per shipment | 1 | $28.0K | 0.7% |
| 10 | CADILA HEALTHCARE LTD Avg $19.9K per shipment | 1 | $19.9K | 0.5% |
This table shows the top 10 of 16 Indian companies exporting levofloxacin to United States, ranked by total trade value. The listed exporters are: ZYDUS LIFESCIENCES LIMITED, DR.REDDY'S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED, HETERO LABS LIMITED, MACLEODS PHARMACEUTICALS LTD, DR REDDYS LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LIMITED, CADILA HEALTHCARE LIMITED, RUBICON RESEARCH LIMITED, CADILA HEALTHCARE LTD. ZYDUS LIFESCIENCES LIMITED is the dominant supplier with 51 shipments worth $1.8M USD, giving it a 46% market share. The top 3 suppliers together account for 79% of the total trade value on this route.
Showing top 10 of 16 total Indian exporters on the India to United States Levofloxacin export route.
Top 10 Levofloxacin Importers in United States
Showing top 10 of 23 known buyers in United States receiving Levofloxacin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian levofloxacin in United States include EVERSANA LIFE SCIENCE SERVICES, DR. REDDYS LABORATORIES, INC, DR. REDDYS LABORATORIES INC, DR REDDYS LABORATORIES,INC, XXMBEXXPHAXXACEXXICAXX IXX, among 23 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $1.8M USD across 55 shipments — representing 48% of all levofloxacin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 55 | $1.8M | 48.1% |
| 2 | DR. REDDYS LABORATORIES, INC | 9 | $275.4K | 7.2% |
| 3 | DR. REDDYS LABORATORIES INC | 3 | $262.7K | 6.8% |
| 4 | DR REDDYS LABORATORIES,INC | 7 | $255.0K | 6.6% |
| 5 | XXMBEXXPHAXXACEXXICAXX IXX | 5 | $238.0K | 6.2% |
| 6 | DR. REDDY'S LABORATORIES, INC | 8 | $205.5K | 5.3% |
| 7 | DR REDDY SLABORATORIES INC | 4 | $119.5K | 3.1% |
| 8 | MACLEODS PHARMA USA,INC | 5 | $109.8K | 2.9% |
| 9 | MACLEODS PHARMA USA.INC | 5 | $83.9K | 2.2% |
| 10 | MACLEODS PHARMA USA INC | 2 | $79.7K | 2.1% |
Showing top 10 of 23 Levofloxacin importers in United States on this route.
Top 10 Levofloxacin Formulations Imported by United States
Showing top 10 of 81 product formulations shipped on the India to United States Levofloxacin route, ranked by trade value
United States imports a wide range of levofloxacin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LEVOFLOXACIN TABLETS USP 750MG [1X20 PERPACK] — accounts for $425.8K USD across 1 shipments. There are 81 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LEVOFLOXACIN TABLETS USP 750MG [1X20 PERPACK] | 1 | $425.8K | 11.1% |
| 2 | PHARMA : LEVOFLOXACIN TABLETS USP 750MG(LEVOFLOXACIN USP 750MG) - 9792 PAC X 1X20 TABS | 1 | $344.7K | 9.0% |
| 3 | LEVOFLOXACIN TABLETS USP 500 MG - 1 X 50 | 6 | $195.6K | 5.1% |
| 4 | LEVOFLOXACIN TABLETS USP 250MG [1X50 PERPACK] | 1 | $192.8K | 5.0% |
| 5 | LEVOFLOXACIN 500MG TABLETS (1X50'S) | 2 | $133.9K | 3.5% |
| 6 | LEVOFLOXACIN TABLETS 500MG 50S (41952 X50S PACKS=2097600 NOS) | 3 | $127.3K | 3.3% |
| 7 | LEVOFLOXACIN TABLETS USP 750MG [1X30 PERPACK] | 1 | $126.3K | 3.3% |
| 8 | LEVOFLOXACIN TABLETS 500MG 50S (TOTAL QTY 36360 X 50S=1818000 NOS) | 1 | $108.3K | 2.8% |
| 9 | LEVOFLOXACIN TABLETS 750MG 30S (39528 X30S PACKS=1185840 NOS) | 1 | $100.5K | 2.6% |
| 10 | LEVOFLOXACIN TABLETS 750MG 30S (TOTAL QTY PACKS 39648 X 30S=1189440 NOS) | 1 | $100.0K | 2.6% |
Showing top 10 of 81 Levofloxacin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 24 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's levofloxacin exports to United States are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 51 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 16 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, DR.REDDY'S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED — together account for 79% of total trade value on this route. The average shipment value of $30.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma : levofloxacin tablets usp 750mg(levofloxacin usp 750mg) - 9792 pac x 1x20 tabs and levofloxacin tablets usp 500 mg - 1 x 50, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 55 shipments worth $1.8M USD — representing 48% of all levofloxacin imports from India on this route. A total of 23 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.8M
- Avg. Shipment
- $30.3K
- Suppliers
- 16
- Buyers
- 23
- Transit (Sea)
- ~31 days
- Annual Growth
- +20.1%
Related Analysis
Reverse Direction
United States → India — Levofloxacin (Import)Other Levofloxacin Routes
Unlock the Full India to United States Levofloxacin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 127 shipments on this route.
Frequently Asked Questions — India to United States Levofloxacin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Levofloxacin to United States?
The leading Indian exporters of Levofloxacin to United States are ZYDUS LIFESCIENCES LIMITED, DR.REDDY'S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED. ZYDUS LIFESCIENCES LIMITED holds the largest market share at approximately 46% of total trade value on this route.
Q What is the total value of Levofloxacin exports from India to United States?
India exports Levofloxacin to United States worth approximately $3.8M USD across 127 recorded shipments. The average value per shipment is $30.3K USD.
Q Which ports does India use to ship Levofloxacin to United States?
The most active port of origin is MUNDRA SEA with 24 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to United States for Levofloxacin?
The average transit time for Levofloxacin shipments from India to United States is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Levofloxacin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.1% with demand growth tracking at 19.0%. The route is ranked #7 among India's top Levofloxacin export destinations globally.
Q How many suppliers are active on the India to United States Levofloxacin route?
There are currently 16 active Indian suppliers exporting Levofloxacin to United States. The market is moderately concentrated with ZYDUS LIFESCIENCES LIMITED accounting for 46% of total shipment value.
Q Who are the main importers of Levofloxacin from India in United States?
The leading importers of Indian Levofloxacin in United States include EVERSANA LIFE SCIENCE SERVICES, DR. REDDYS LABORATORIES, INC, DR. REDDYS LABORATORIES INC, DR REDDYS LABORATORIES,INC, XXMBEXXPHAXXACEXXICAXX IXX. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 55 shipments worth $1.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Levofloxacin.
- 2.Supplier/Buyer Matching: 16 Indian exporters and 23 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 127 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
127 Verified Shipments
16 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists